EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artificial Intelligence-Enhanced Molecular Profiling of JAK-STAT Pathway Alterations in FOLFOX-Treated Early-Onset Colorectal Cancer

Fernando C Diaz iD, Brigette Waldrup iD, Francisco G Carranza iD, Sophia Manjarrez iD, Enrique Velazquez-Villarreal iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27010479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Fernando C Diaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Janus Kinases, STAT Transcription Factors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, NCI, City of Hope Cancer Control and Population Sciences program by the National Institutes of Health, NIH, National Cancer Institute, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early-onset colorectal cancer (EOCRC) continues to rise, with the steepest increases observed among Hispanic/Latino (H/L) populations, underscoring the urgency of identifying ancestry- and treatment-specific biomarkers. The JAK-STAT signaling axis plays a central role in colorectal tumor biology, yet its relevance under FOLFOX-based chemotherapy in EOCRC remains poorly defined. In this study, we evaluated 2515 colorectal cancer (CRC) cases (266 H/L; 2249 non-Hispanic White [NHW]), stratifying analyses by ancestry, age of onset, and FOLFOX exposure. Statistical comparisons were performed using Fisher’s exact and chi-square tests, and survival patterns were assessed via Kaplan–Meier analysis. To extend conventional analytics, we deployed AI-HOPE and AI-HOPE-JAK-STAT, conversational artificial intelligence platforms capable of harmonizing genomic, clinical, demographic, and treatment variables through natural language queries, to accelerate multi-parameter biomarker exploration. JAK-STAT pathway alterations showed marked variation by ancestry and treatment context. Among H/L EOCRC cases, alterations were significantly enriched in patients who did not receive FOLFOX compared with those who did (21.2% vs. 4.1%; p = 0.003). A similar pattern emerged in late-onset CRC (LOCRC) NHW patients, where alterations were more frequent without FOLFOX exposure (13.3% vs. 7.5%; p = 0.0002). Notably, JAK-STAT alterations were significantly more common in untreated H/L EOCRC compared with untreated NHW EOCRC (21.2% vs. 9.9%; p = 0.002). Survival analyses revealed that JAK-STAT pathway alterations conferred improved overall survival across several NHW strata, including EOCRC treated with FOLFOX (p = 0.0008), EOCRC not treated with FOLFOX (p = 0.07), and LOCRC not treated with FOLFOX (p = 0.01). These findings suggest that JAK-STAT alterations may function as ancestry- and treatment-dependent prognostic markers in EOCRC, particularly among disproportionately affected H/L patients. However, prognostic interpretation in H/L subgroups is limited by small mutation-positive sample sizes, reflecting historical underrepresentation and highlighting the need for larger ancestry-balanced studies. The integration of AI-enabled platforms streamlined analyses and reveals the potential of artificial intelligence to accelerate discovery and advance precision medicine for populations historically underrepresented in cancer genomics research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsJanus KinasesSTAT Transcription FactorsArtificial IntelligenceHumansFluorouracilLeucovorinSignal TransductionFemaleMaleOrganoplatinum CompoundsMiddle AgedBiomarkers, TumorAge of OnsetAdultAged

Stichwörter der Autor:innen

AI-agentsFOLFOX chemotherapyHispanic/LatinoJAK-STAT signaling pathwayartificial intelligencebiomarkerscolorectal cancerearly-onset colorectal cancerhealth disparitiestumor suppressor

Substanzen

FluorouracilLeucovorinJanus KinasesSTAT Transcription FactorsOrganoplatinum CompoundsBiomarkers, Tumor

Autor:innen und Institutionen

  • Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA.
  • Department of Integrative Translational Sciences, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.
  • City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.

ORCID-Profile: Fernando C Diaz, Brigette Waldrup, Francisco G Carranza, Sophia Manjarrez, Enrique Velazquez-Villarreal

Förderung

  • NCI NIH HHS
  • National Cancer Institute, NCI
  • City of Hope Cancer Control and Population Sciences program by the National Institutes of Health, NIH, National Cancer Institute, NCI
  • Drug Development and Capacity Building: A UCR/CoH-CCC Partnership project by the National Institutes of Health, NIH, National Cancer Institute, NCI

Zitieren

APA

Diaz, F. C., Waldrup, B., Carranza, F. G., Manjarrez, S., & Velazquez-Villarreal, E. (2026). Artificial Intelligence-Enhanced Molecular Profiling of JAK-STAT Pathway Alterations in FOLFOX-Treated Early-Onset Colorectal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010479

Vancouver

Diaz FC, Waldrup B, Carranza FG, Manjarrez S, Velazquez-Villarreal E. Artificial Intelligence-Enhanced Molecular Profiling of JAK-STAT Pathway Alterations in FOLFOX-Treated Early-Onset Colorectal Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27010479

BibTeX
@article{Diaz2026,
  author = {Diaz, Fernando C and Waldrup, Brigette and Carranza, Francisco G and Manjarrez, Sophia and Velazquez-Villarreal, Enrique},
  title = {Artificial Intelligence-Enhanced Molecular Profiling of JAK-STAT Pathway Alterations in FOLFOX-Treated Early-Onset Colorectal Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27010479}
}
Kostenlos starten →